These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22233979)

  • 1. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure.
    Al-Majed NS; McAlister FA; Bakal JA; Ezekowitz JA
    Ann Intern Med; 2011 Mar; 154(6):401-12. PubMed ID: 21320922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.
    Rosanio S; Schwarz ER; Ahmad M; Jammula P; Vitarelli A; Uretsky BF; Birnbaum Y; Ware DL; Atar S; Saeed M
    Am J Cardiol; 2005 Sep; 96(5):710-7. PubMed ID: 16125501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
    Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS
    Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy.
    Abraham WT
    Prog Cardiovasc Dis; 2006; 48(4):232-8. PubMed ID: 16517245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in cardiac resynchronization therapy.
    Steffel J; Holzmeister J; Abraham WT
    Postgrad Med; 2011 Mar; 123(2):18-26. PubMed ID: 21474889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
    Zaręba W
    Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European CRT Survey: 1 year (9-15 months) follow-up results.
    Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
    Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whom should I refer in 2014 for cardiac resynchronization?
    Manlucu J; Tang AS
    Can J Cardiol; 2014 Jun; 30(6):675-8. PubMed ID: 24882541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.